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Abstract
Pluripotency genes are implicated in mouse embryonic genome activation (EGA) and pluripotent lineage specification.
Moreover, their expression levels have been correlated with embryonic term development. In bovine, however, little
information is available about dynamics of pluripotency genes during these processes. In this study, we charted quantitative
and/or qualitative spatio-temporal expression patterns of transcripts and proteins of pluripotency genes (OCT4, SOX2 and
NANOG) and mRNA levels of some of their downstream targets in bovine oocytes and early embryos. Furthermore, to
correlate expression patterns of these genes with term developmental potential, we used cloned embryos, having similar in
vitro but different full term development rates. Our findings affirm: firstly, the core triad of pluripotency genes is probably
not implicated in bovine EGA since their proteins were not detected during pre-EGA phase, despite the transcripts for OCT4
and SOX2 were present. Secondly, an earlier ICM specification of transcripts and proteins of SOX2 and NANOG makes them
pertinent candidates of bovine pluripotent lineage specification than OCT4. Thirdly, embryos with low term development
potential have higher transcription rates; nevertheless, precarious balance between pluripotency genes is maintained. This
balance presages normal in vitro development but, probably higher transcription rate disturbs it at later stage that
abrogates term development.
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Introduction
Oogenesis is characterised by the accumulation of a myriad of
maternal transcripts and proteins in the oocyte. These transcripts
and proteins, referred to as maternal factors, are the products of
‘‘maternal-effect’’ genes. In the mouse, considerable information is
available on maternal-effect genes and their roles in embryonic
development. These factors endow oocytes with the ability to
optimise follicular development, the maturation of germ cells,
early embryonic development and particularly embryonic genome
activation (EGA) [1] which is necessary to the transition from a
maternal to an embryonic control of embryo development (MET).
In mice, embryonic genome activation is primarily elicited
through an improved access of the transcription factors to the
embryonic genome after its remodelling. These factors include a
homeodomain containing transcription factor (Oct4/Pou5f1) and
an SRY-related HMG-box containing factor (Sox2) [2]. Interest-
ingly, Oct4 and Sox2 are expressed during oogenesis and their
transcripts and proteins persist in the early embryo [3,4]. The
expression patterns of these factors presage their roles in
embryonic development before and after EGA. Consistent with
this idea, functional studies have demonstrated that before EGA, a
depletion of Oct4 at the 1-cell stage abrogates embryonic
development [5] and critical levels of Sox2 are necessary to
achieve successful EGA [6]. After EGA Sox2 deficient embryos
halt their development at the morula stage and are unable to
differentiate their trophectoderm [7]. At the blastocyst stage, Oct4
is responsible for the lineage specification of the inner-cell-mass
(ICM) and is down-regulated in the trophectoderm (TE) [3],
whereas, SOX2 plays important role in maintaining the ICM
through hetero-dimerization with OCT4, and its down-regulation
leads to embryonic lethality [4].
It is worth mentioning here that Oct4 and Sox2 are not simply
maternal-effect genes that are implicated in vivo; they also endow
pluripotency on embryonic stem cells (ESC) in vitro [8].
Interestingly, the remarkable properties of ES cells are attributed
to a set of three ‘‘master-regulators’’ :two of them are mentioned
above (Oct4 and Sox2) and the third actor is Nanog [9]. Nanog is not
expressed in early embryos until morula and is not a maternal-
effect gene [10]. In fact, Nanog is activated through the expression
of Oct4 and Sox2 in mouse and human ES cells [11]. These three
genes collaboratively control the ‘‘ground state’’ pluripotency in
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prompt in vitro differentiation of ES cells. It has been observed
that Oct4 or Sox2 knockdown direct ES cells to differentiate into the
trophectoderm lineage [13,14,15], and Nanog ablation in human
ES cells causes extra-embryonic endoderm lineage differentiation
[16]. Moreover, the advent of direct reprogramming through the
ectopic expression of pluripotency transcription factors has further
emphasised their role. In fact, the retroviral induction of Oct4 and
Sox2 in the human fibroblasts is sufficient to reprogram these cells
to the pluripotent state (Induced pluripotent cells or iPS cells) [17]
and they are also required for reprogramming mouse fibroblasts
[18]. Understanding and dissecting the regulatory mechanisms
that underlie the state of pluripotency have been the subject of
wide ranging analyses. Indeed these three pluripotency factors
elicit the transcriptional activation of other pluripotency genes
through a positive feedback to themselves and the transcriptional
repression of lineage-specifying factors [12].
In addition to early development and lineage specification,
pluripotency genes have also been implicated in the long-term
development potential of mouse embryos [19]. In this context,
pluripotency transcription factors play pivotal roles in mice, since
they control early embryonic development, EGA, pluripotent
lineage (ICM) specification and ES cells derivation as well as long-
term embryonic development. However, little information is
available on these processes in bovine, despite the data that has
accumulated to demonstrate species-specific differences in the
processes of early development and lineage specification [20]. For
example, the major burst of embryonic genome activation takes
place after several cleavages (8–16 cell stage) in bovine, compared
to the 2-cell stage in mice [21], with regulatory mechanisms that
remain largely cryptic. Similarly, the establishment of the
pluripotent lineage proceeds differently in different species. This
is evident from the fact that Oct4 is expressed in the ICM and TE
of bovine and porcine blastocysts [20,22,23]. Moreover, to our
knowledge, the spatio-temporal expression profile of Sox2 has not
yet been addressed in bovine embryos. However, NANOG protein
is found to be ICM specific in bovine blastocysts [24]. It is
therefore speculated that due to the lack of information on these
basic processes and their controlling mechanisms in bovine
embryos, efforts to derive bovine ES cells have largely been
fruitless [25].
In addition to the species-specific differences, defective devel-
opment and female sterility can hamper the development of gene-
targeting experiments to study the process of bovine MET.
However, somatic cell nuclear reprogramming in cloning
experiments represents an interesting tool to study the important
events during development in bovine. In nuclear transplantation
(cloning) a differentiated somatic cell nucleus is transformed into
an undifferentiated totipotent (capable of developing into a whole
individual) state when inserted in an enucleated oocyte. This
implies huge epigenetic changes that result in a transition from a
somatic to an embryonic gene expression pattern and is referred to
as ‘‘nuclear reprogramming’’ [26]. And indeed, nuclear repro-
gramming in cloning experiments is equivalent to MET in a
context of natural fertilization insofar as both result in establish-
ment of totipotency [27]. In fact, nuclear reprogramming results
from nucleo-ooplasmic interactions. Interestingly, the effects of
different cell types in cloning efficiency have already been
documented [28]; moreover, a variation in full-term development
potential has been observed using different cell lines of the same
cell type [27,29], which could be anticipated by means of gene
expression analyses as early as the morula stage in bovine [30]. We
therefore speculated that identifying aberrations in the pluripo-
tency gene expression patterns of cloned morulae derived from
somatic cell nuclear transfer (SCNT) from cell lines with different
term developmental potentials might be an interesting approach to
study the role of these genes in optimum MET and long-term
embryonic development.
In order to address this issue, the objectives of the present study
in bovine were firstly, to reveal the dynamics of the pluripotency
genes products (mRNA and proteins) during two key develop-
mental steps: EGA, and establishment of the pluripotent lineage
during blastocyst formation and secondly, to consider a possible
relationship between the levels of pluripotency genes expression
and the long-term development potential of bovine embryos using
cloned bovine embryos.
Materials and Methods
1. Preparation and Collection of Biological Material
Gene expression analyses of genes of pluripotency and their
downstream targets were performed on the same batches of
embryos/oocytes.
1.1 Immature, Mature Oocytes and IVF Embryos. Bo-
vine ovaries were collected from the slaughterhouse (Socopa, cours
Saint Paul, 27110 Le Neubourg, France); oocytes with diameter of
2–7 mm were aspirated from the follicles. Some of the immature
oocytes (GV) used for gene expression analysis were dry-frozen
after the selection and removal of cumulus cells by gentle
pipetting. The rest of the selected cumulus oocyte complexes
(COCs) were placed in the maturation medium [31]. Mature
oocytes and fertilized embryos were obtained after in vitro oocyte
maturation, fertilization and embryo culture as described
previously [32,33]. Mature oocytes (MII) intended to be used for
gene expression analysis were collected 24 hrs post maturation
(hpm) and cumulus cells were removed after treatment with
hyaluronidase (HEPES-buffered TCM 199 with 0.5%
hyaluronidase). The denuded MII oocytes were then dry-frozen.
IVF embryos were also collected and frozen at appropriate stages.
Generally, 4-cell embryos (4-cell) were recovered 41 hrs post-
insemination (hpi), 8 to 16-cell embryos at 72 hpi, early morulae
were collected at 120 hpi and blastocysts were obtained at day 7
(E7) post-insemination. Furthermore, the embryos for in situ
hybridization and immunofluorescence were also collected at days
7 to 9 (E7, E8 and E9) post-insemination.
1.2 Somatic Donor Cell Culture. Primary cultures of
bovine fibroblasts were derived from ear skin biopsies of two
separate Holstein heifers, OV5538 (here named Somatic cell A)
and OV029 (here named Somatic cell B). These cells were frozen-
stored at passage 1 (previously described in [30,34]) and used as
sources of donor nuclei for Nuclear Transfer (NT) between
passages 3 to 12. Donor fibroblasts were grown for 5 days in
Dulbecco’s Modified Eagle Medium (DMEM; Life Technologies,
Cergy, France) supplemented with 10% FCS (Life Technologies)
at 38uC with 5% CO2. During this period the cells reached
confluence and were synchronized to G0/G1 of the cell cycle
through contact inhibition. Nuclear donor cells were trypsinized at
37uC for 5 min and were re-suspended in 1 mL DMEM
supplemented with 10% fetal calf serum (FCS) for nuclear
transfer. Somatic cells for gene expression analysis were also
cultured as described above.
1.3 Nuclear Transfer Embryos. Recipient oocytes were
matured in vitro as previously described [32] and enucleated at
20–22 hpm (hours post-maturation). SCNT embryos were
reconstructed by the electrofusion of enucleated oocytes with
donor cells at 23–24 hpm (2.0 kV/cm 30 ms 62 pulses). The
reconstructed embryos were activated by incubation for 5 h after
fusion, in 10 mg/ml cycloheximide (Sigma) and 5 mg/ml
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serum. Activated embryos were co-cultured under the same
conditions as the IVF embryos [33]. Grade 1 morulae, defined as
in [35] (Clone Morula A and Clone Morula B) were selected at
120 hours post-fusion and immediately dry-frozen for further
molecular analysis.
2. Spatio-temporal Gene Expression Analysis
2.1 RNA Extraction and Reverse Transcription. Em-
bryonic total RNAs were extracted from batches of embryos
(n=30 embryos) using the PicoPure RNA extraction kit
(Arcturus). The challenges of a loss of embryonic RNA during
column purification and later the normalization of qRT-PCR data
were addressed through the addition of a carrier RNA (16S–28S
carrier, Roche Diagnostics, Meylan, France) and an exogenous
transcript (Luciferase, Promega) at the time of extraction. In order
to enhance the RNA recovery rate and estimate the number of
‘equivalent embryos’ in the sample after purification, we added
2.5 mg carrier RNA to the samples. The carrier RNA recovery
rate was estimated by OD measurement, while embryonic RNA
was considered to be negligible when compared to the carrier
RNA. This recovery rate was taken into account to calculate the
number of equivalent embryos left in each sample after column
purification. In addition, luciferase encoding reporter transcripts
was added 1 pg per embryo along with carrier for qRT-PCR data
normalisation as an exogenous control. A purification procedure
using DNAse I (Qiagen) treatment at 25uC for 15 min was
performed prior to elution.
Total RNA was subjected to RT-PCR and the cDNAs were
synthesized using the Superscript III enzyme (Invitrogen) and
hexamer random primers (Roche Diagnostics, Meylan, France) in
20 ml final volume. RT-PCR products were diluted so as to obtain
1 equivalent embryo per 10 ml. Quantitative PCR was performed
on 0.5 or 1 equivalent embryos per well in 96-well plates,
depending upon the gene of interest.
The RNA extraction of somatic cells was performed in order to
obtain three independent biological quantifications. Four dishes
were cultured concomitantly to confluence from a single cell
suspension. One dish was used to count the cells, while cells from
the three other dishes were recovered for RNA extraction using
the Qiagen minikit. Total RNAs were subjected to cDNA
synthesis as described for embryos. The cDNAs of somatic cells
were diluted to obtain an equivalent of 3000 cells in 10 mlo fR T
product.
2.2 Real Time qRT-PCR. Before performing qRT-PCR on
the samples included in these experiments, the specificity of the
primers was validated for the IVF embryos and further verified on
2% agarose gel. Primer sequences are provided in the table 1.
Moreover, the appropriate number of equivalent embryos
required per well for each gene was determined by analysing the
correlation between the number of copies obtained for 0.5, 1 and 2
equivalent embryos per well using the same concentration of
primers. The reactions were performed on an ABI Prism 7000
sequence detector (Applied Biosystems). Each gene was run
separately and a 10-fold dilution series of quantified amplicon
was included in each run to determine the standard curve. This
experiment consisted of three biological repetitions and three
technical replicates for each PCR reaction (n=9 for each sample
stage) as well as for the standard curve. The cDNA consisting of an
appropriate number of equivalent embryos or somatic cells in a
volume of 10 ml was added to the PCR mix containing 12.5 mlo f
26 SybrGreen Mastermix (Applied Biosystems, Courtaboeuf,
France), 0.25 ml Uracyl N-glycosylase (1 U/ml), 0.5 ml of each
primer (10 mM initial concentration) and 1.25 mlH 2O to obtain a
final volume of 25 ml. The thermal cyclic profile started with a
2 min step at 50uC, followed by 10 min at 95uC, and 45 cycles
each consisting of denaturation for 15 sec at 95uC, and annealing
and extension for 60 sec at 60uC. Dissociation curves were
obtained after each PCR run to ensure that a single PCR product
had been amplified.
The numbers of copies of each gene were determined based
upon their standard curves. The qRT-PCR data were normalised
using the geometric mean of the endogenous genes GAPD, SDHA
and YWHAZ, which have been shown to be an appropriate set of
reference genes for pre-implantation bovine embryos [36], while
exogenous normalisation with luciferase was performed in the case
of cloned embryos [30]. Three biological repetitions were
performed for each developmental stage and the mean Ct value
for each repetition was obtained from a technical triplicate. The
number of copies for each biological repetition was calculated
using a standard dilution curve obtained with each reaction. The
ratio values for each stage of embryos were obtained from each
biological repetition divided by the geometric mean of the control
genes corresponding to that biological repetition, and then the
mean of the three biological repetitions was taken. Error bars
represent 6SEM.
2.3 In situ Hybridization (ISH). The bovine cDNA
fragments encoding OCT4, NANOG and SOX2 were derived
from PCR amplifications, sequenced, cloned into pGEMT-Easy
(Promega) and in vitro transcribed using the Sp6 RNA polymerase
for anti-sense probes and T7 RNA polymerase to generate the
sense probes as described in [37]. The OCT4, NANOG and SOX2
antisens probes correspond to the NCBI entries DQ126156,
DQ126153.1 and DQ126150 respectively. The blastocysts at E7,
E8 and E9 were fixed in 4% paraformaldehyde and subjected to
whole-mount in situ hybridization as described in [38,39]. Briefly,
samples were permeabilised with proteinase K (10 mg/ml in PBS-
Tween) for 10 mn before hybridization with Dig-labelled
Table 1. Primers used for the qRT-PCR of different genes.
Name Primer Sequence
Product
Size
OCT4 F:GGCGCCAGAGGAAAGGATAC
R:AGAAGGGCAAACGATCAAGCA
173
SOX2 F:CCATGCAGGTTGACATCGT
R:ACACAACTACGGAAACTAAAAGTGG
184
NANOG F:AACAACTGGCCGAGGAATAG
R:AGGAGTGGTTGCTCCAAGAC
193
STAT3 F:GACCTTTTCAGATAAGAGGGAGACA
R:GCAGCAGGAAATCTCCAAGGA
198
HESX1 F:ACTGTGTTCCATCCACGAAACC
R:CAAACACTTTCTTCCGGGACTG
152
MEIS1 F:TCGGGAAGGATGGGAAA
R:CCAAGGTGGGACTATGGAAA
289
NODAL F:CTCCGCTTCCCATAGCAG
R:CCTGTTCACTGTCACTCTGTCC
206
ISL1 F:TTATCATTGGGCTGCTGTTG
R:CCTGCTATGCCGCTAACC
169
SDHA F: GCAGAACCTGATGCTTTGTG
R: CGTAGGAGAGCGTGTGCTT
185
YWHAZ F: GCATCCCACAGACTATTTCC
R: GCAAAGACAATGACAGACCAs
120
GAPD F: TTCAACGGCACAGTCAAGG
R: ACATACTCAGCACCAGCATCAC
119
doi:10.1371/journal.pone.0034110.t001
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samples were incubated in BM purple (Roche) until the colour
developed. The hybridized embryos were observed under an
inverted microscope and photographed using a digital camera
(Zeiss).
3. Spatio-temporal Protein Expression Pattern
3.1 Immunofluorescence. Immature (GV), mature bovine
oocytes (MII), 4-cell, 8-cell, 16-cell, early morula (25–30 cells) and
blastocysts at days E7, E8 and E9 were fixed in 4% (w/v)
paraformaldehyde (PAF). The oocytes and embryos were then
washed in PBS for 10 min. The samples were permeabilized with
1.0% (v/v) Triton X-100/PBS for 1 hr at room temperature. The
zona pellucida of embryos at the blastocyst stage was removed and
the embryos were opened manually to enable better access for the
antibodies to the ICM. Furthermore, oocytes and embryos were
boiled in 10 mM sodium citrate buffer [40] and then maintained
at a sub-boiling temperature for 10 min for the antigen unmasking
procedure. The samples were rinsed in PBS and then incubated
with 2% (w/v) BSA-PBS for 1 h. Then the oocytes and embryos
were incubated with primary antibody diluted in 2% (w/v) BSA-
PBS for 2 hr at room temperature (RT). The embryos were then
rinsed in PBS solution and incubated with secondary antibody
diluted in PBS-BSA for 45 min at RT. After washing with PBS,
the nuclei of the embryos were counter-stained with DAPI and
mounted on the glass slides with anti-fading medium (Vectashield,
Vector Laboratories, Burlingame, CA, USA). The immuno-
fluorescent–labelled oocytes and embryos were observed under a
fluorescent microscope (Axioplan imaging Apotome apparatus,
Zeiss, Germany) (MIMA2 Platform, INRA, Jouy en Josas, France).
3.2 Western Blot. Immature (GV), mature bovine oocytes
(MII), 4-cell, 8-cell, 16-cell, early morula (25–30 cells) and
blastocysts at days E7, E8 and E9 were lysed with sodium
dodecyl sulfate (SDS)-buffer. The embryonic polypeptides were
separated through 4–12% Bis- Tris Gel NuPage gel
electrophoresis, as previously described [41]. Protein molecular
weight markers (14–200 kD, Amersham) were run simultaneously
as molecular weight standards. Electrophoretically separated
polypeptides were transferred onto a polyvinylidene difluoride
membrane (Hybond-P PVDF, Amersham). The membranes were
blocked with 1/1000 Tween 20-PBS (PBS-T, Prolabo, France)
containing 4% (w/v) non-fat dried milk. The membranes were
then incubated with primary antibodies for 2 hrs at room
temperature and washed three times with PBS-T and incubated
with secondary anti-rabbit antibody conjugated with peroxidase,
followed again by washing three times in PBS-T. Peroxidase
activity was revealed using the ECL-Plus Western Blot detection
system (Amersham). The signals were analysed using the Image
Analysis system (Advanced Image Data Analyzer software, LAS
1000 camera, Fuji films).
Primary antibodies. OCT4 protein was labelled with a
rabbit polyclonal anti-OCT4 antibody (Abcam; 1:150 in PBS–
BSA for immunofluorescence and 1/500 in PBS –T 4% non-fat
dried milk for Western blot). NANOG was labelled with a rabbit
polyclonal anti-NANOG antibody (Reprotech; 1:500 in PBS–BSA
for immunofluorescence and 1/1000 in PBS–T 4% non-fat dried
milk for Western blot). SOX2 was labelled with a mouse
monoclonal anti SOX2 antibody (R&D Systems; 1:50 in PBS–
BSA for immunofluorescence and 1/250 in PBS –T4% non-fat
dried milk for Western blot).
Secondary antibodies. A fluorescein isothiocyanate (FITC)-
labelled anti-rabbit secondary antibody (Jackson Immunoresearch;
1:500) or a peroxydase-conjugated anti-rabbit IgG antibody (1/
5000; Santa Cruz Biotechnology), were used.
Statistical Analysis
The statistical significance of the levels of gene expression
patterns was determined using one-way ANOVA with STATIS-
TICA 9.1 software (StatSoft, Inc. USA.).
Results
1. Expression of OCT4, SOX2 and NANOG in early bovine
embryos
First of all, we charted the temporal expression profiles of the
three principal pluripotency genes (OCT4, SOX2 and NANOG)i n
oocytes and early bovine embryos using qRT-PCR. The
quantification results were normalized using the geometric mean
of the three endogenous genes GAPD, SDHA and YWHAZ, because
this has been shown to be the best combination of housekeeping
genes for the normalization of qPCR data during early
development in bovine [36]. Under these conditions, the qRT-
PCR results revealed variations in the relative expressions of
candidate genes in the total transcriptome of the embryo. In
addition, we articulated the spatial compartmentalization of these
transcripts into the earliest lineages (ICM and TE) from a
qualitative point of view, using in situ hybridization in bovine
blastocysts. Immunofluorescence was then performed on OCT4,
SOX2 and NANOG to detect the proteins, and the results were
further confirmed by Western Blot analysis.
OCT4 transcripts were detected in the oocytes at the germinal
vesicles (GV) stage, although at low levels. The levels of OCT4
mRNA remained unchanged until the 8–16 cell stage. The highest
level of OCT4 expression was observed at the early morula stage
(25–30 cells). Likewise, OCT4 expression remained high at the
blastocyst stage (E7); however, its relative level was significantly
lower than in the morula (Fig. 1A). In situ hybridization revealed
the ubiquitous presence of OCT4 in the ICM and trophectoderm
at E7 and E8 (Fig. 1D–E). By contrast, at E9, OCT4 was restricted
to the ICM although a few cells were still positive in the TE
(Fig. 1F).
Using immunofluorescence, OCT4 protein was not detectable
in oocytes and early embryos until the 8-cell stage. At the 16-cell
stage (which marks the end of EGA), a very weak OCT4 signal
was detected in blastomere nuclei (data not shown). The early
morula stage was the first point at which we detected a strong
OCT4 labelling in all nuclei. OCT4 protein in the E7, E8 and E9
blastocysts was detectable in cells of both the ICM and TE, but,
the nuclei of ICM blastomeres displayed apparently stronger
labelling than the TE at all these stages. Moreover, we observed a
gradual tendency towards OCT4 protein restriction in the ICM
from E7 to E8 and E9 (Fig. 2A). Immunofluorescence detection
findings agreed with the Western Blot analysis which revealed a
polypeptide at 43 kD in the morula (more than 32 cells) and
blastocyst (Fig. 2B). The earlier stages were negative for OCT4.
Furthermore, we confirmed the antibody specificity by using
mouse ES cells as positive controls and bovine fibroblast cells as
negative controls (Fig. 2B).
In bovine, SOX2 mRNA was detected in the GV and metaphase
II (MII) oocyte stages. The relative level of SOX2 fell significantly
at the 4-cell stage but tended to increase at the 8–16 cell stage,
leading to the highest level of SOX2 in the early morula
transcriptome. Nevertheless, a major decrease in the relative level
of expression was observed at the E7 blastocyst stage (Fig. 1B). In
situ hybridization experiments revealed a restriction of SOX2
transcripts to the ICM at E8 and E9. Trophectoderm cells,
however, were weakly labelled in their cytoplasm at E7. This
labelling disappeared at E8 and E9, while the ICM became more
intensely labelled (Fig. 1G–I).
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the 8-cell stage using immunofluorescence. The earliest specific
detection of SOX2 was in the nuclei of early morulae.
Interestingly, SOX2 protein was detected in E7, E8 and E9
blastocysts. At these stages only the nuclei of ICM blastomeres
were labelled and the TE was negative (Fig. 2A). Furthermore, our
results were confirmed using Western Blot, which showed a single
polypeptide of 39 kD (the expected molecular weight) that was
only detectable in the morula and blastocyst (Fig. 2C).
The NANOG transcript was not detectable using qRT-PCR in
the GV, MII oocytes or 4 cell stage embryos. NANOG transcript
levels started to rise above background level at the 8–16-cell stage.
NANOG was at its peak at the early morula stage and then slightly
but non-significantly declined at E7 blastocyst (Fig. 1C). In situ
hybridization was sufficiently sensitive to detect NANOG in the
ICM of E7, E8 and E9 blastocysts compared to the negative
controls, while TE was not labelled at all (Fig. 1J–L).
We did not observe any specific nuclear labelling of the
NANOG protein between the oocyte and the 8-cell stage (Fig. 2A)
and even 16-cell stage (data not shown), using immunofluores-
cence. At the early morula stage, a specific nucleolar labelling was
seen in all blastomeres which persisted until E9. In addition of this,
in the ICM a specific nucleoplasmic labelling persisted from E7 to
E9. Western Blot analysis revealed the existence of two NANOG
protein polypeptides in early bovine embryos, at 28 kD from the
oocyte to the morula stage and at 50 kD at the blastocyst stage
(Fig. 2D). We assumed the possibility of NANOG dimerization, in
accordance with data in the literature [42], which had reported
that NANOG forms homodimers, detectable by Western Blot in
order to exert its pluripotency function.
2. Expression profile of few genes involved in Signalling
Pathway or Early Patterning in early bovine embryos
To further investigate pluripotency reprogramming in early
bovine embryos, we analyzed the expression patterns of few genes
known to be involved either in signalling pathways regulating
pluripotency or in early patterning in the mouse model. Two genes
involved two different signalling pathways in ES cells were chosen:
Stat3 belongs to a JAK-STAT signalling pathway, while Nodal is a
member of the TGF-beta family that constitutes an alternate
signalling pathway. We choose HESX1, MEIS 1 and ISL1 as early
patterning genes because they encode transcription factors
involved in numerous functions during embryo development and
because master regulators of pluripotency OCT4, SOX2 and
NANOG) have been shown to bind their regulatory regions in ES
cells [12]. We therefore analysed the expression patterns of these
five genes (hereafter referred to as SP/EP for Signalling Pathway/
Early Patterning genes) in bovine embryos using qRT-PCR
(Fig. 3A–E). The expression profiles of these genes revealed their
overall resemblance during the course of pre-implantation
development, except for MEIS1. In fact, the transcripts of these
genes were abundant in GV and MII oocytes, whereas after
fertilization they gradually regressed to reach their lowest
concentrations at the blastocyst stage. However, MEIS1 increased
transiently at the 4-cell stage and then declined progressively until
the blastocyst stage.
Figure 1. Expression profiles and transcript localization of pluripotency genes during bovine pre-implantation development of the
bovine embryos. Expression profiles of OCT4, SOX2 and NANOG (A–C) were charted using qRT-PCR at pre-implantation stages of bovine oocytes/
embryos: GV (Germinal Vesicle), MII (Metaphase 2 oocyte), 4-cell stage, 8–16-cell stage, Morula (25–30 cells) and E7 (Day 7 blastocyst). The results
were normalised using the geometric mean of the endogenous GAPD, SDHA and YWHAZ genes. Values are means 6 SEM of one equivalent embryo/
oocyte. The experiment was repeated three times and each repetition contained a triplicate of each sample stage. The localization and
compartmentalization of OCT4 (D–F), SOX2 (G–I) and NANOG (J–L) was determined by whole mount in situ hybridization (ISH) in a spatio-temporal
manner from day7 to day9 (E7, E8 and E9) blastocysts. Encircled regions demarcate the ICM.
doi:10.1371/journal.pone.0034110.g001
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In this part of the study, we investigated the reprogramming of
pluripotency genes in cloned bovine early morulae with different
potentials (A=12.7% vs. B=1.8%, referred to respectively as
5538 and 029 in [30] for full-term development). This difference
depends upon the origin of the fibroblasts used as nuclear donors,
which are derived from two different animals. Here, we studied
the expression levels of the pluripotency genes in bovine morulae
derived through cloning and compared them with control IVF
morulae as well as with their donor somatic cells.
It is worth mentioning here that the global transcriptome of
cloned embryos is not directly comparable to that of fertilized
embryos [27,30]. Therefore, the genes used to normalise qRT-
PCR results in the fertilized embryos could not be used in the
cloned embryos unless otherwise tested. Since there have so far
been no studies that have tested endogenous genes for the
normalisation of qRT-PCR results comparing cloned and IVF
bovine embryos, we adopted a two step strategy. Firstly,w e
supposed that if the expression levels of the three endogenous
control genes GAPD, SDHA and YWHAZ in the three types of
morulae (two types of cloned and IVF morulae) were similar, these
genes could be used as endogenous reference genes. However, our
findings showed that the expression pattern of each of these
endogenous control genes was not uniform between the three
types of morulae when normalised to an exogenous luciferase
transcript added at a constant level per embryo in each sample at
the time of RNA extraction. B cloned morulae expressed higher
levels of these genes on a per embryo basis (Fig. 4A–C). Secondly,
because the expression levels of the endogenous genes were not
similar; these genes could not be used as qRT-PCR control genes.
We therefore decided to use the exogenous luciferase transcript,
added at a constant level per embryo, as a reporter gene to
normalise the results of qRT-PCR when comparing cloned and
IVF early morulae.
Under these conditions, we observed no differences in the levels
of expression of any of the three pluripotency genes between the
fertilised embryo and the cloned embryo with better term
developmental potential (Clone Morula A). However, Clone
Embryo B (with poor developmental potential until term)
displayed significantly higher levels of expression of all three
pluripotency genes (Fig. 5A–C). Furthermore, we compared the
expression levels of the SP/EP genes with quantifiable expression
at the morula stage; i.e. STAT3, ISL1 and MEIS1, in both cloned
and IVF morulae and observed that STAT3 and ISL1 were
expressed at significantly higher level in clone Morula B than in
Clone Morula A and the IVF controls. However, there was no
significant difference in MEIS1 expression between the three types
of morulae (Fig. 6A–C).
Figure 2. Protein expression of pluripotency genes in the early bovine embryos. Immunofluorescent detection of OCT4, SOX2 and NANOG
protein was done in the pre-implantation bovine embryos/oocytes: GV (Germinal Vesicle), MII (Metaphase 2 oocyte), 4-cell stage, 8–16-cell stage and
Morula (25–30 cells) using immunofluorescence (A) and Western Blot (B-D). Protein compartmentalization in the ICM/TE was also studied at E7 (Day 7
blastocyst), E8 (Day 8 blastocyst) and E9 (Day 9 blastocyst) as well. Encircled areas demarcate the ICM.
doi:10.1371/journal.pone.0034110.g002
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pluripotency genes and SP/EP genes in cloned B morulae could
be due to a differential expression of these genes in donor cells. We
thus compared the expression levels of the pluripotency genes and
SP/EP genes in the two types of somatic donor cells. However, we
were not able to quantify pluripotency gene expression in donor
cells: even with 3000 cells, the Ct for qRT-PCR experiments were
out of the reference scale, despite the high sensitivity of our PCR
conditions that made it possible to quantify about ten transcripts
per sample (data not shown). We thus concluded that these genes
were not expressed in donor fibroblasts, whatever their origin (A or
B). Performing the same comparison with SP/EP genes, we were
unable to evidence any difference in expression between A and B
donor cells (Figure 7 A–E). These genes were significantly down-
regulated after nuclear reprogramming, as illustrated by a per cell
comparison of their expression in donor fibroblasts and in cloned
embryos. We thus concluded that the higher expression of the
pluripotency genes and most of the SP/EP genes in clone morulae
with poorer full-term development potential was not due to their
previously higher expression in the corresponding donor cells.
Figure 3. Expression patterns of the ST/EP genes. Expression profiles of STAT3, NODAL, HESX1, MEIS1 and ISL1 (A–E) were charted using qRT-
PCR during the pre-implantation stages of bovine oocytes/embryos: GV (Germinal Vesicle), MII (Metaphase 2 oocyte), 4-cell stage, 8–16-cell stage,
Morula (25–30 cells) and E7 (Day 7 blastocyst). The results were normalised using the geometric mean of endogenous GAPD, SDHA and YWHAZ genes.
Values are means 6 SEM of one equivalent embryo/oocyte. The experiment was repeated three times and each repetition contained a triplicate of
each sample stage.
doi:10.1371/journal.pone.0034110.g003
Figure 4. Expression patterns of endogenous control genes in bovine IVF and cloned embryos. Expression levels of the endogenous
control genes GAPD, SDHA and YWHAZ were determined in bovine IVF and cloned morulae (Clone Morula A=better developmental potential and
Clone Morula B=poorer developmental potential). Results were normalised with exogenous transcript luciferase.
doi:10.1371/journal.pone.0034110.g004
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SP/EP transcripts in poor quality clones presented an interesting
paradox when trying to derive any conclusions from these results.
We supposed that because normalisation with an exogenous
transcript provided a per embryo-based quantification of a specific
transcript rather than its relative abundance within an embryo, the
observation of higher levels of pluripotency and SP/EP transcripts
in these poor quality clones might either be due to a larger number
of cells in these embryos or a generally larger quantity of all
transcripts leading to a higher mRNA content. In order to address
this problem despite the morphological similarity of the three types
of early morulae we analysed, it was decided to precisely count the
number of cells in all three types of morulae (two types of clones
and the fertilized morulae). No significant difference was seen in
the number of cells contained in the three types of morulae (Fig. 8).
It was therefore possible to conclude as to the existence of
differences in the expression levels of numerous genes, including
the pluripotency genes, between cloned embryos with poorer
potentials for full-term development and fertilized embryos.
Discussion
To our knowledge, this is the first study in bovine to have
simultaneously revealed spatio-temporal expression patterns of the
transcripts and proteins of the core pluripotency genes (OCT4,
SOX2 and NANOG) and the mRNA expression levels of the five
SP/EP genes in oocytes and early embryos.
1. Expression of OCT4, SOX2 and NANOG in bovine early
embryos
a) Expression profiles and spatial distribution of
pluripotency transcripts. Our findings showed maternal
contribution of the OCT4 and SOX2 mRNA in bovine embryos.
Furthermore, the highest levels of all three pluripotency genes at
morula stage indicated that these genes are also transcribed by the
embryo after EGA. These observations agree with the findings of
studies in mice [2,43]. In bovine, similar OCT4 expression has
been documented in qualitative and semi-quantitative studies
[22,44], but the present study reports for the first time on SOX2
and NANOG expression in multiple early stages of bovine embryos.
The qualitative spatial distribution analysis of OCT4 and SOX2
transcripts revealed their ubiquitous presence in the ICM and TE
Figure 5. Expression patterns of genes of pluripotency in bovine cloned embryos. Expression patterns of OCT4, SOX2 and NANOG were
determined in bovine cloned morulae (Clone Morula A and Clone Morula B) and were compared with the levels of expression of these genes in
controls (IVF Morulae). The results of qRT-PCR in all three types of morulae were normalised using an exogenous transcript luciferase. Values are
means 6 SEM of one equivalent embryo. The experiment was repeated three times and each repetition contained a triplicate of each sample.
doi:10.1371/journal.pone.0034110.g005
Figure 6. Expression patterns of SP/EP genes in bovine cloned embryos. Expression levels of STAT3, NODAL, HESX1, MEIS1 and ISL1 were
determined in bovine cloned morulae (Clone Morula A=better developmental potential and Clone Morula B=poorer developmental potential) and
were compared with the levels of these genes in control IVF morulae (Morula). NODAL and HESX1 were not detectable at morula stage so the data is
not shown. The results of qRT-PCR were normalised using an exogenous transcript luciferase. Values are means 6 SEM of one equivalent embryo/
oocyte. The experiment was repeated three times and each repetition contained a triplicate of each sample.
doi:10.1371/journal.pone.0034110.g006
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as soon as the blastocyst formed. The presence of OCT4 in the
ICM and TE corroborates previous findings in bovine [23], while
in mice, OCT4 and SOX2 transcripts are ICM-specific as soon as
the formation of the blastocyst [3,4]. NANOG specificity in the
ICM in bovine, on the other hand, was similar to that seen in mice
and humans [43]. We consider this finding to be significant with
respect to early lineage differentiation in bovine. Indeed, a recent
study aptly focused on TE lineage determination in bovine and
found that the bovine OCT4 promoter lacks the TCFAP2 binding
sites that are responsible for early OCT4 repression in the mouse
TE [20]. However, the roles of collaborative factors such as SOX2
Figure 7. Expression patterns of SP/EP genes in the somatic donor cells and bovine cloned embryos derived from these cells.
Expression levels of STAT3, NODAL, HESX1, MEIS1 and ISL1 were determined in bovine cloned morulae (Clone Morula A=better developmental
potential and Clone Morula B=poorer developmental potential) and their somatic donor cells (Somatic Cell A=Fibroblast cells 5538 and Somatic Cell
B=Fibroblast cells 029). The data represents number of transcript molecules in a single cell in the somatic cells as well as cloned morulae. The results
of qRT-PCR were normalised using an exogenous transcript luciferase. Values are means 6 SEM of one equivalent cell. The experiment was repeated
three times and each repetition contained a triplicate of each sample.
doi:10.1371/journal.pone.0034110.g007
Figure 8. Number of cells in early bovine IVF and cloned morulae. The number of cells in each type of morula (Morula (IVF), Clone Morula A
and Clone Morula B) was counted by staining the nuclei. Thirty embryos were used to calculate the number of cells derived from three different trials.
doi:10.1371/journal.pone.0034110.g008
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suggest that pluripotency may become restricted to the ICM quite
earlier because of NANOG restriction to this lineage.
b) Expression profiles and spatial distribution of
pluripotency proteins. Despite the presence of maternal
OCT4 transcripts, OCT4 protein was not detectable in oocytes
or early embryos until it was first detected in the nuclei of early
morula cells. In blastocysts, OCT4 was observed in cell nuclei of
both the ICM and TE. These findings clearly corroborate earlier
observations of OCT4 in the ICM and TE of bovine blastocysts
[20,22]. However, the only study in the literature to have
addressed OCT4 detection in bovine during pre-EGA stages
mentioned the detection of OCT4 in the oocyte and early embryos
(before the 16-cell stage) [22]. Unfortunately, antibody specificity
in that study was not verified using any method other than
immunofluorescence. We performed Western Blot analysis which
is in concordance with our immunofluorescence results. We
suppose that technical differences, particularly with respect to
antibody specificity, could have caused this contradiction with
previous published results. The absence of OCT4 from oocytes
and early embryos, however, presented an interesting paradox. In
fact, OCT4 is found throughout early development in the mouse
and is one of the maternal effect genes which may halt the
embryonic development if it is disrupted [45]. Further, gene
knockdown study in the mouse has emphasised its role during
EGA [5]. Functional analyses are therefore necessary to precisely
assign the role of OCT4 in early bovine embryos.
SOX2 was first observed in the nuclei of early bovine morulae.
We assumed that the faint fluorescent signal observed before that
stage is only unspecific background because it is exclusively
cytoplasmic and is also observed in control experiments omitting
the first antibody (data not shown). In mouse, maternal SOX2 has
been shown to modulate gene reprogramming during EGA and is
localized in the nucleus of the oocyte and 1-cell stage embryo [6].
According to our data this is not the case in bovine embryos. At a
later stage, E7 blastocysts were characterized by the nuclear
labelling of SOX2 in the ICM, while it was absent from the
trophectoderm. Therefore, SOX2 seems to be a more pertinent
candidate of pluripotent lineage specification than OCT4 in
bovine.
In the pre-EGA phase, NANOG was not detectable using
immunofluorescence until the 8-cell stage. Before that stage, the
faint cytoplasmic immunofluorescent labelling was not different
from that observed in control experiments omitting the first
antibody (data not shown). All cells in the morula displayed
nucleolar labelling. Blastocysts had similar nucleolar labelling in
the TE, whereas in ICM cells both nucleoplasmic and nucleolar
labelling were observed at E7, E8 and E9.
Such a nucleolar labelling for NANOG has not been described
in mouse [46] and bovine embryos [47]. But a similar
nucleoplasmic and nucleolar labelling has been described in the
goat [48] and in early bovine blastocyst explants [47] using the
same anti-NANOG antibody as us. To get further insight into this
peculiar staining, we performed Western Blot analysis which
revealed that oocyte and embryos up to the morula stage displayed
a 28 kD band whereas embryos at E7 to E9 contained both 28 kD
and 50 kD bands. The specificity of the 28 kD band was
confirmed by pre-adsorption of the antibody solution with
recombinant NANOG protein (data not shown). According to
the literature [42] Nanog forms homodimers in order to exert its
pluripotency function. We supposed that the 50 kD homodimeric
form corresponds to the nucleoplasmic form in ICM cells, which
are the pluripotent lineage. The 28 kD polypeptide would thus
correspond to the nucleolar form which we hypothesized is
recognized in immunofluorescence experiments only when
concentrated in the nucleoli. It has been considered that the
nucleolar protein would not be involved in pluripotency [47].
Moreover, the sequestration of proteins in the nucleoli has been
proposed to be involved in the inactivation process that ultimately
leads to ubiquitination and degradation of the transcription factor
[49].
2. Expression profiles of SP/EP genes in early bovine
embryos
In the present study, we analysed the expression profiles of some
important genes involved in pluripotency signalling pathways or
early patterning.
Our findings indicated that these transcripts were contributed
maternally and were degraded during the MET process. The only
exception is MEIS1 which is up-regulated transiently at the 4-cell
stage concomitant with bovine minor-EGA. These genes encode
for factors involved in differentiation and patterning during
development. In mice, for example, Hesx1is required for normal
neuroectoderm formation [50], Stat3 knockdown leads to embry-
onic death at day 6.5 [51], Isl1 knockdown leads to developmental
arrest and death at day 9.5 in mice [52] and Nodal is involved in
patterning of early embryo during the mesoderm and endoderm
formation [53]. Because the transcriptional activation of these
genes does not occur immediately after EGA, it can therefore be
assumed that they are down-regulated during early development
and expressed later at appropriate time points during develop-
ment. Interestingly in the early embryo the expression patterns of
STAT3, HESX1, MEIS1 and ISL1 are globally similar (with
maternal transcripts progressively degraded, and no expression at
EGA) and seems opposite to the expression patterns of
pluripotency master genes. This appears to differ from the
situation described in mouse and human ES cells where Meis1
and Isl1 are down-regulated but Stat3 and Hesx1 are up-regulated
because of Oct4, Sox2 and Nanog binding [12]. We first have to
notice that maternal transcripts for these genes may have been
expressed earlier during oogenesis when the expression of
pluripotency factors has not been documented so far, then stably
stored. Concerning the absence of embryonic transcription, these
results point to the difference between ES cells and early embryo’s
genomes which are in different epigenetic states [54]. It is also
worth mentioning that transcription is only poorly regulated in ES
cells which are probably more prone to gene transcription than
early embryonic genome [55]. Finally, we cannot exclude
interspecies variations in the regulation of these genes by
pluripotency factors.
3. Expression patterns of pluripotency genes and their
SP/EP genes in cloned bovine embryos
The significance of gene knockdown strategies to analyse the
functional importance of a particular gene is unquestionable, but
they provide insufficient insights into the short or long term effects
caused by small variations in the gene expression level. It is known
that if an embryo acquires a proper gene expression pattern after
EGA, embryonic development potential may be better, as
embryonic death and senescence may ensue otherwise [56]. In
this context, we hypothesised that the expression levels of
pluripotency genes could be related to embryo development
potential in bovine.
Intriguingly, the comparison of the three types of morulae
showed that the morula with a poorer potential for development to
term (Clone Morula B) expressed significantly higher levels of all of
the genes analysed, including the pluripotency genes and their
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expression of nearly all the genes tested at the early morula stage
was a unique observation which was not due to a significantly
higher number of cells in the Clone Morula B. We thus assumed
that Clone Morula B contained higher levels of a large proportion
of its total messenger RNAs resulting from higher transcription
rate. One may argue that higher transcript level at morula might
have been due to malfunction of the degradation of maternally
contributed factors such as OCT4, SOX2, STAT3, and ISL1. But an
average three-fold increase in the level of transcripts in Clone
Morula B compared to IVF morulae, seemed impossible to be due
to degradation failure alone. This notion is supported by the
higher levels of NANOG transcripts in Clone Morula B which has
no maternal contribution. We thus conclude to a higher
transcription rate of multiple genes including the pluripotency
genes in Clone Morula B. More detailed analyses are necessary to
ascertain the precise epigenetic reasons for this over-expression
which at least for pluripotency genes was not due to a difference in
their transcription rate in donor cells.
The functional consequences of gene overexpression on the
embryonic development raised new questions. Indeed, normal
embryonic development requires an appropriate formation of
pluripotent epiblast and extraembryonic tissues. The over-
expression of pluripotency genes may directly or indirectly affect
these processes to cause embryonic death. This has been reported
for a single gene over-expression [57], however, in Clone Morula
B the three pluripotency genes (OCT4, NANOG and SOX2) were
concomitantly over-expressed and their precise ratio remained the
same as in IVF control embryos. This observation was interesting,
because it has recently been proposed that Oct4, Sox2 and Nanog
could be lineage specifiers and a precarious balance between them
would result in pluripotency [58]. If this supposition is true then
Clone Morula B should be devoid of any detrimental effects on
their early development and blastocyst formation. The higher
levels of pluripotency genes could result in developmental failure
of Clone Morula B at later stage when the balance between these
genes becomes disturbed. This explanation is compatible with
experimental data since Clone Morula A and B had similar rates
of blastocyst formation; however, after embryo transfer Clone
Morula B displayed morphological abnormalities at peri-implan-
tation stages (Degrelle et al. in preparation) and rarely developed
to birth. In addition, gene over-expression is not limited to
pluripotency genes but concerns a large number of genes in Clone
Morula B. We suppose that the over-expression of pluripotency
factors could be responsible for a global higher transcription rate
after EGA in bovine as evidenced at EGA in the mouse [5,6].
In conclusion, the results of the present study provide valuable
new insights into the gene dynamics in the particular context of
maternal to embryonic transition (MET) and early lineage
differentiation. Our findings affirm that firstly, the transcripts of
OCT4 and SOX2 arise from both the maternal and embryonic
genomes, while NANOG is synthesised by the embryo alone and
none of the proteins of these genes is of maternal origin, except for
a monomeric form of NANOG which is supposed not to be
functional. Therefore, these genes probably do not play major
roles in bovine EGA. Secondly, bovine pluripotent lineage
specification segues progressively in line with development. The
transcript and protein localisation experiments show an earlier
ICM specific compartmentalization of both SOX2 and NANOG
compared to OCT4, thus these two genes represent interesting
candidates for pluripotent lineage specification and require
functional analyses. In addition, cloned embryos proved to be a
complementary ‘‘real-life’’ alternative for the classic functional
studies, which report correlation between the induced up or down-
regulation of a single gene in the embryos and their developmental
potential [57]. Our findings support the notion that the expression
levels of pluripotency genes may presage the long term
developmental potential of bovine embryos.
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